跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17 条关于
“Sydnexis”
全部
17
临床试验
0
药物
2
机构
4
资讯
11
10个月前
FDA Issues Complete Response Letter to Sydnexis for SYD-101 Pediatric Myopia Treatment
去年
FDA Accepts NDA for Sydnexis' SYD-101: First Potential Pharmaceutical Treatment for Pediatric Myopia
2个月前
FDA to Convene Advisory Committee to Review Sydnexis's SYD-101 for Pediatric Progressive Myopia
9个月前
FDA Rejection of Low-Dose Atropine Sparks Industry Petition and Calls for Myopia Reclassification
10个月前
SCYNEXIS Completes BREXAFEMME NDA Transfer to GSK, Enabling Antifungal Drug Relaunch
10个月前
SCYNEXIS Secures $35 Million NIH Grant to Advance Next-Generation Antifungal Therapeutics
8个月前
SCYNEXIS Receives FDA Fast Track and QIDP Designations for SCY-247 Antifungal Therapy
去年
SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247 for Invasive Fungal Infections
去年
SCYNEXIS Presents Promising Data on SCY-247 Against Drug-Resistant Fungal Infections at TIMM-12 Congress
11个月前
Kynexis Initiates Phase 2 Trial of First-in-Class KAT-II Inhibitor for Schizophrenia-Associated Cognitive Impairment
第 1 页,共 2 页
上一页
下一页